GT Biopharma, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
GT Biopharma, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q3 2024.
  • GT Biopharma, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 10, 2024 was 2.23M shares, a 94.6% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 2.23M -39.2M -94.6% Nov 10, 2024 10-Q 2024-11-14
Q2 2024 2.23M -38.4M -94.5% Aug 10, 2024 10-Q 2024-08-14
Q1 2024 1.38M -35.4M -96.2% Mar 26, 2024 10-K 2024-03-26
Q3 2023 41.4M +8.86M +27.2% Nov 1, 2023 10-Q 2023-11-01
Q2 2023 40.6M +10.1M +33.2% Aug 7, 2023 10-Q 2023-08-07
Q1 2023 36.8M +4.69M +14.6% Mar 30, 2023 10-K 2023-03-30
Q3 2022 32.6M +1.98M +6.46% Oct 31, 2022 10-Q 2022-10-31
Q2 2022 30.5M May 16, 2022 10-Q 2022-05-16
Q1 2022 32.1M +3.73M +13.1% Mar 28, 2022 10-K 2022-03-28
Q3 2021 30.6M -47.7M -60.9% Nov 12, 2021 10-Q 2021-11-10
Q1 2021 28.4M -42.2M -59.8% Apr 12, 2021 10-K 2021-04-16
Q3 2020 78.3M +10.8M +16.1% Nov 11, 2020 10-Q 2020-11-13
Q2 2020 76.6M +10.4M +15.7% Aug 11, 2020 10-Q/A 2020-08-18
Q1 2020 70.6M +19.2M +37.4% Mar 23, 2020 10-K 2020-03-27
Q3 2019 67.4M +17.2M +34.3% Nov 14, 2019 10-Q 2019-11-14
Q2 2019 66.1M +16M +32% Aug 11, 2019 10-Q 2019-08-14
Q1 2019 51.4M +1.26M +2.51% Mar 6, 2019 10-K 2019-03-29
Q3 2018 50.2M +460K +0.92% Nov 14, 2018 10-Q 2018-11-14
Q2 2018 50.1M +49.6M +9995% Aug 14, 2018 10-Q 2018-08-14
Q1 2018 50.1M -72.8M -59.2% Feb 28, 2018 10-K 2018-03-01
Q3 2017 49.8M +19.5M +64.6% Nov 14, 2017 10-Q 2017-11-14
Q2 2017 496K -26.4M -98.2% Aug 11, 2017 10-Q 2017-08-11
Q1 2017 123M +101M +471% Mar 28, 2017 10-K/A 2018-02-28
Q3 2016 30.2M -570M -95% Nov 14, 2016 10-Q/A 2018-02-28
Q2 2016 26.9M -573M -95.5% Aug 1, 2016 10-Q/A 2018-02-28
Q1 2016 21.5M -578M -96.4% Mar 27, 2016 10-K/A 2018-02-28
Q3 2015 600M +8.29M +1.4% Nov 13, 2015 10-Q 2015-11-13
Q2 2015 600M Aug 14, 2015 10-Q 2015-08-14
Q1 2015 600M Mar 27, 2015 10-K 2015-03-31
Q4 2014 592M Jan 7, 2015 10-Q 2015-01-08
Q3 2014 592M Oct 23, 2014 10-K 2014-11-18
Q3 2012 457M +242M +112% Sep 30, 2012 10-Q 2012-11-21
Q2 2012 364M Jun 30, 2012 10-Q/A 2012-09-13
Q1 2012 269M Apr 13, 2012 10-K 2012-04-16
Q4 2011 239M Nov 21, 2011 10-Q 2011-11-21
Q3 2011 215M Aug 15, 2011 10-Q/A 2011-09-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.